Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht(TUM Klinikum), John M. Davis(University of Illinois Chicago), Loukia M. Spineli(University of Ioannina), Corrado Barbui(University of Verona), Bettina Lässig(München Klinik), Franziska Richter(Technical University of Munich), Myrto Samara(Klinikum rechts der Isar), Werner Kissling, Marko Paul Stapf(Klinikum rechts der Isar), John Geddes(University of Oxford), Dimitris Mavridis(Délégation Paris 5), Georgia Salanti(University of Bern), Deniz Örey(Technical University of Munich), Rolf R. Engel, Andrea Cipriani(Oxford Health NHS Foundation Trust)
Cited by 2,540
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
|World Psychiatry|2011|2.5k
Graphical Tools for Network Meta-Analysis in STATA
|PLoS ONE|2013|2.5k